These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
465 related articles for article (PubMed ID: 34570947)
1. Prevalence of SARS-CoV-2 antibodies among nurses: A systematic review and meta-analysis. He S; Hecimovic A; Matijasevic V; Mai HT; Heslop L; Foster J; Alexander KE; Pal N; Alexandrou E; Davidson PM; Frost SA J Clin Nurs; 2022 Jun; 31(11-12):1557-1569. PubMed ID: 34570947 [TBL] [Abstract][Full Text] [Related]
2. Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis. Galanis P; Vraka I; Fragkou D; Bilali A; Kaitelidou D J Hosp Infect; 2021 Feb; 108():120-134. PubMed ID: 33212126 [TBL] [Abstract][Full Text] [Related]
3. The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis. Kayı İ; Madran B; Keske Ş; Karanfil Ö; Arribas JR; Psheniсhnaya N; Petrosillo N; Gönen M; Ergönül Ö Clin Microbiol Infect; 2021 Sep; 27(9):1242-1249. PubMed ID: 34116205 [TBL] [Abstract][Full Text] [Related]
4. Global seroprevalence of SARS-CoV-2 antibodies: A systematic review and meta-analysis. Bobrovitz N; Arora RK; Cao C; Boucher E; Liu M; Donnici C; Yanes-Lane M; Whelan M; Perlman-Arrow S; Chen J; Rahim H; Ilincic N; Segal M; Duarte N; Van Wyk J; Yan T; Atmaja A; Rocco S; Joseph A; Penny L; Clifton DA; Williamson T; Yansouni CP; Evans TG; Chevrier J; Papenburg J; Cheng MP PLoS One; 2021; 16(6):e0252617. PubMed ID: 34161316 [TBL] [Abstract][Full Text] [Related]
5. Global SARS-CoV-2 seroprevalence from January 2020 to April 2022: A systematic review and meta-analysis of standardized population-based studies. Bergeri I; Whelan MG; Ware H; Subissi L; Nardone A; Lewis HC; Li Z; Ma X; Valenciano M; Cheng B; Al Ariqi L; Rashidian A; Okeibunor J; Azim T; Wijesinghe P; Le LV; Vaughan A; Pebody R; Vicari A; Yan T; Yanes-Lane M; Cao C; Clifton DA; Cheng MP; Papenburg J; Buckeridge D; Bobrovitz N; Arora RK; Van Kerkhove MD; PLoS Med; 2022 Nov; 19(11):e1004107. PubMed ID: 36355774 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of IgG antibodies against SARS-CoV-2 in India, March 2020 to August 2021: a systematic review and meta-analysis. Jahan N; Brahma A; Kumar MS; Bagepally BS; Ponnaiah M; Bhatnagar T; Murhekar MV Int J Infect Dis; 2022 Mar; 116():59-67. PubMed ID: 34968773 [TBL] [Abstract][Full Text] [Related]
7. A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines. Wattal C; Oberoi JK; Goel N; Datta S; Raveendran R; Rao BK; Kumar R Indian J Med Microbiol; 2021; 39(4):528-533. PubMed ID: 34688485 [TBL] [Abstract][Full Text] [Related]
8. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala. Davila-Siliezar P; Wer A; Barnoya J Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801 [TBL] [Abstract][Full Text] [Related]
9. SARS-CoV-2 seroprevalence around the world: an updated systematic review and meta-analysis. Azami M; Moradi Y; Moradkhani A; Aghaei A Eur J Med Res; 2022 Jun; 27(1):81. PubMed ID: 35655237 [TBL] [Abstract][Full Text] [Related]
10. Seroprevalence of SARS-CoV-2 Antibodies in Africa: A Systematic Review and Meta-Analysis. Hajissa K; Islam MA; Hassan SA; Zaidah AR; Ismail N; Mohamed Z Int J Environ Res Public Health; 2022 Jun; 19(12):. PubMed ID: 35742506 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 Seroprevalence Among Health Care Workers in Major Private and Public Hospitals With COVID-19 Patient's Referral in Tehran, Iran. Darvishian M; Sharafkhah M; Mohammadi Z; Sadeghniiat-Haghighi K; Abdollahi A; Jafary M; Talaschian M; Tabarsi P; Baghai P; Mardani M; Shayanrad A; Shafighian F; Markarian M; Roozafzai F; Zamani M; Alvand S; Hariri S; Sadeghi A; Poustchi H; Malekzadeh R Front Public Health; 2022; 10():832003. PubMed ID: 35400056 [TBL] [Abstract][Full Text] [Related]
12. Seroprevalence of anti-SARS-CoV-2 antibodies in Africa: A systematic review and meta-analysis. Chisale MRO; Ramazanu S; Mwale SE; Kumwenda P; Chipeta M; Kaminga AC; Nkhata O; Nyambalo B; Chavura E; Mbakaya BC Rev Med Virol; 2022 Mar; 32(2):e2271. PubMed ID: 34228851 [TBL] [Abstract][Full Text] [Related]
13. Seroprevalence of the SARS-CoV-2 antibody in healthcare workers: a multicentre cross-sectional study in 10 Colombian cities. Malagón-Rojas JN; Mercado-Reyes M; Toloza-Pérez YG; Parra Barrera EL; Palma M; Muñoz E; López R; Almentero J; Rubio VV; Ibáñez E; Téllez E; Delgado-Murcia LG; Jimenez CP; Viasus-Pérez D; Galindo M; Lagos L; Occup Environ Med; 2022 Jun; 79(6):388-395. PubMed ID: 34740981 [TBL] [Abstract][Full Text] [Related]
14. Seroprevalence of SARS-CoV-2 IgG antibodies among health care workers prior to vaccine administration in Europe, the USA and East Asia: A systematic review and meta-analysis. Hossain A; Nasrullah SM; Tasnim Z; Hasan MK; Hasan MM EClinicalMedicine; 2021 Mar; 33():100770. PubMed ID: 33718853 [TBL] [Abstract][Full Text] [Related]
15. Severe Acute Respiratory Syndrome Coronavirus-2 seroprevalence in South-Central Uganda, during 2019-2021. Ssuuna C; Galiwango RM; Kankaka EN; Kagaayi J; Ndyanabo A; Kigozi G; Nakigozi G; Lutalo T; Ssekubugu R; Wasswa JB; Mayinja A; Nakibuuka MC; Jamiru S; Oketch JB; Muwanga E; Chang LW; Grabowski MK; Wawer M; Gray R; Anderson M; Stec M; Cloherty G; Laeyendecker O; Reynolds SJ; Quinn TC; Serwadda D BMC Infect Dis; 2022 Feb; 22(1):174. PubMed ID: 35189840 [TBL] [Abstract][Full Text] [Related]
16. Update on SARS-CoV-2 seroprevalence: regional and worldwide. Rostami A; Sepidarkish M; Fazlzadeh A; Mokdad AH; Sattarnezhad A; Esfandyari S; Riahi SM; Mollalo A; Dooki ME; Bayani M; Nazemipour M; Mansournia MA; Hotez PJ; Gasser RB Clin Microbiol Infect; 2021 Dec; 27(12):1762-1771. PubMed ID: 34582980 [TBL] [Abstract][Full Text] [Related]
17. Seroprevalence of SARS-CoV-2 in Brazil: A systematic review and meta-analysis. Figueiredo GM; Tengan FM; Campos SR; Luna EJ Clinics (Sao Paulo); 2023; 78():100233. PubMed ID: 37348256 [TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Anti-SARS-CoV-2 Antibodies among Municipal Staff in the Municipality of Prishtina. Gashi B; Osmani V; Halili R; Hoxha T; Kamberi A; Hoti N; Agahi R; Basha V; Berisha V; Hoxha I Int J Environ Res Public Health; 2021 Nov; 18(23):. PubMed ID: 34886272 [TBL] [Abstract][Full Text] [Related]
20. Higher rate of SARS-CoV-2 IgG seropositivity in hospital-based healthcare workers compared to elderly care staff in a Swedish low-prevalence region: a cross-sectional study. Ocias LF; Skogstam A; Kjerstadius T; Lundin F; Tevell S Infect Dis (Lond); 2021; 53(12):920-929. PubMed ID: 34350813 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]